IRLAB's Drug Candidates IRL942 and IRL1009 Have Been Granted Patents in the US and Europe

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- IRLAB announced today that drug candidates IRL942 and IRL1009 have been granted composition of matter patents in the US and Europe from respective authorities.